CGRP Inhibitors Market to Reach $12.5 Billion by 2033 Amid Growing Migraine Awareness

Market for CGRP inhibitors is expanding due to advances in migraine treatment…

Lilly’s Verve 102 Shows Promise as a Treatment for High Cholesterol

New PCSK9 base editor shows significant reductions in cholesterol levels Verve 102…

Doctor Butler’s Maximum Strength Relief Formula Now Available at Walmart Stores Nationwide

Relief formula now accessible to a larger audience through Walmart retailers. New…

Zero Candida Announces Corporate Changes

Significant leadership shifts aim to enhance company operations Zero Candida announces changes…

Pierre Fabre Laboratories Receives CHMP Positive Opinion for BRAFTOVI

Approval sought for first-line treatment of adult patients with BRAF V600 mutations…

Menarini Group Presents New Data at ASCO 2026 Annual Meeting

Research highlights key advancements in cancer treatment and patient care. Menarini Group…

New Episode of Advancements Airing Saturday, May 30 at 8:00 PM ET

Upcoming episode explores innovations in health technology and research. Upcoming episode focuses…

MGI Tech Secures Three iF Design Awards for Breakthrough in Sequencing and Ultrasound

Recognition highlights innovation in genomic sequencing technology and ultrasound design. MGI Tech…

Eisai Presents Future Sales Simulations for Leqembi at Investor Relations Day

Key insights on Leqembi's market potential shared by Eisai. Eisai highlights potential…

Eisai Presents Future Sales Simulations for Leqembi at Investor Relations Day

Eisai outlines projected sales for Leqembi in its latest presentation. Eisai estimates…